D-Pressin Spray (Desmopressin) Spray

Generic brands for Desmopressin Tablet Available in India Brand Name D-Pressin Spray Generic Name Desmopressin Strength 0.1mg, 0.2mg, 60mg, 120mg Manufacturer United Biotech Pvt Ltd  

Description

Description

This page contains brief details about the drug desmopressin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Desmopressin was first approved by the U.S. Food and Drug Administration (FDA) for medical use on November 1, 1978.

Mechanism of Action of Desmopressin

Desmopressin is a medication that mimics the action of the hormone vasopressin in the body. Its therapeutic effect primarily focuses on regulating water balance and reducing excessive urine production. By increasing water reabsorption in the kidneys, it helps alleviate symptoms of conditions such as central diabetes insipidus and bedwetting (nocturnal enuresis). It can also aid in treating mild to moderate von Willebrand disease by promoting the release of von Willebrand factor, a clotting protein.

Uses of Desmopressin

Desmopressin treats conditions such as diabetes insipidus, bedwetting (nocturnal enuresis), and von Willebrand disease.

Desmopressin Dosage available

Desmopressin can be administered orally in tablet form, as a nasal spray, or through injection. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider. The nasal spray is administered by spraying into the nostrils, alternating nostrils with each dose. A healthcare professional usually gives injections under the skin or into a vein.

We can ship to :

News/Updates

References

  1. AbbVie Lt, Electronic Medicines Compendium (EMC), [Revised on May 2023] [Accessed on 31st August 2023], pil.2217.pdf (medicines.org.uk)
  2. Actavis Pharma, Inc., US Food and Drug Administration, [Revised on Sept 2015] [Accessed on 31st August 2023],  https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204412s006lbl.pdf. 
  3. KD Tripathi, Nonsteroidal Anti-inflammatory Drugs and Antipyretic-Analgesics, Essentials of Medical Pharmacology, 8th Edition, 2019, 209-226.